---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-007738"
form_type: "8-K"
ticker: "IMNM"
cik: "0001472012"
company_name: "Immunome Inc."
filed_at: "2023-01-30T23:59:59+00:00"
generated_at: "2026-06-20T06:34:47.852270+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Immunome posts corporate presentation on website for investor meetings

## Summary
- Posted presentation dated January 2023 under Item 8.01 of Form 8-K.
- Presentation may be used in meetings with investors, analysts, collaborators, vendors.
- Presentation attached as Exhibit 99.1 and incorporated by reference into Item 8.01.
- Report signed by President and CEO Purnanand D. Sarma on January 30, 2023.

## SEC filing metadata
- accession: 0001104659-23-007738
- form_type: 8-K
- ticker: IMNM
- cik: 0001472012
- company_name: Immunome Inc.
- filed_at: 2023-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472012/000110465923007738/0001104659-23-007738-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472012/000110465923007738/tm234730d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-007738
- JSON: https://secwatch.observer/filing/0001104659-23-007738.json
- Plain text: https://secwatch.observer/filing/0001104659-23-007738.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.